TCL Archive NCI Programs: New Grant Programs To Infuse $142 Million Into Tobacco Control Research, Training November 27, 1998
TCL Archive Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial December 25, 2009
TCL Archive FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity? August 15, 1997